Abstract A101: Comorbidities, guideline-concordant treatment, and prostate cancer-specific mortality in California, 2011-2021: A competing risks mediation analysis
Prostate cancer (PCa) is the second-leading cause of cancer-related mortality among men in the United States (US). Comorbidity burden is common among men with PCa and is associated with lower survival, potentially through reduced receipt of guideline-concordant treatment. However, the extent to which receipt of g...